# Silenseed Ltd. — Form D

Silenseed Ltd. of JERUSALEM, L3, a company, filed a Form D exempt-offering notice with the SEC on 2014-04-08. The offering totals $500K, of which $500K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2014-04-08
- Form: D
- Accession: 0001178913-14-001228
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $500K
- Amount sold: $500K
- Investors: 4
- Date of first sale: 2014-03-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-215152

## Issuer

- Name: Silenseed Ltd.
- CIK: 0001602634
- Entity type: Corporation
- Jurisdiction: ISRAEL
- Address: GOLDYNE SAVAD INSTITUTE OF GENE THERAPY, JERUSALEM, L3, 9112001
- Phone: 972 2 6743430

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Shmuel Cabilly | Director | Tel Aviv, L3 |
| Eithan Galun | Director | Jerusalem, L3 |
| Amotz Shemi | Director | Jerusalem, L3 |
| Ilan Shiloah | Director | Jerusalem, L3 |
| Amotz Shemi | Executive Officer | Jerusalem, L3 |

## More

- [CIK 1602634 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1602634&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001178913-14-001228.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.